![Adel Nada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Adel Nada
Vorstandsvorsitzender bei GentiBio, Inc.
Aktive Positionen von Adel Nada
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GentiBio, Inc.
![]() GentiBio, Inc. BiotechnologyHealth Technology GentiBio, Inc. engages in the development of engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. The company was founded by Adel Nada, David Rawlings, Jane H. Buckner, and Gideon Gross and is headquartered in Seattle, WA. | Vorstandsvorsitzender | - | - |
Gründer | - | - | |
Präsident | - | - | |
Alia Therapeutics Srl
![]() Alia Therapeutics Srl BiotechnologyHealth Technology Alia Therapeutics Srl engages in experimental research activities in the field of biotechnology. It specializes in the identification of new technologies for genome modification. The company was founded by Gianluca Petris, Antonio Casini, and Anna Cereseto and is headquartered in Trento, Italy. | Direktor/Vorstandsmitglied | 09.05.2023 | - |
Independent Dir/Board Member | 09.05.2023 | - |
Karriereverlauf von Adel Nada
Ehemalige bekannte Positionen von Adel Nada
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Caladrius Biosciences, Inc.
![]() Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 11.04.2014 | - |
Ausbildung von Adel Nada
Alexandria University | Doctorate Degree |
Rush University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
2 | |
Italien | 2 |
Operativ
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Caladrius Biosciences, Inc.
![]() Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
GentiBio, Inc.
![]() GentiBio, Inc. BiotechnologyHealth Technology GentiBio, Inc. engages in the development of engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. The company was founded by Adel Nada, David Rawlings, Jane H. Buckner, and Gideon Gross and is headquartered in Seattle, WA. | Health Technology |
Alia Therapeutics Srl
![]() Alia Therapeutics Srl BiotechnologyHealth Technology Alia Therapeutics Srl engages in experimental research activities in the field of biotechnology. It specializes in the identification of new technologies for genome modification. The company was founded by Gianluca Petris, Antonio Casini, and Anna Cereseto and is headquartered in Trento, Italy. | Health Technology |